Page 2 - Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ascendis must wait 3 more months for FDA verdict on TransCon PTH

Ascendis must wait 3 more months for FDA verdict on TransCon PTH
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesJan mikkelsenAscendis pharmaEuropean commissionAccess programExpanded access program

FDA Extends Review Period for Hypoparathyroidism Treatment TransCon PTH

FDA Extends Review Period for Hypoparathyroidism Treatment TransCon PTH
empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.

United statesJan mikkelsenAscendis pharmaAccess programDrug administrationNew drug applicationComplete response letterPrescription drug user fee actExpanded access program

Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Nevan elamChristen baglaneasTirtht patelRezolute incAccess programSecurities exchangeChief executive officerPipeline progressSprague dawleyExpanded access programMacular edemaSpectral domain ocular coherence tomographySecurities actSecurities exchange actPrivate securities litigation reform actRisk factors

Ascendis Pharma (ASND) Announces Extension of U S Food and Drug Administration Review Period for TransCon™ PTH for Adults with Hypoparathyroidism

Ascendis Pharma (ASND) Announces Extension of U S Food and Drug Administration Review Period for TransCon™ PTH for Adults with Hypoparathyroidism
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAscendis pharmaJan mikkelsenDrug administrationAccess programNew drug applicationChief executiveExpanded access program

FDA Extends Review for TransCon PTH in Hypoparathyroidism to August 2024

FDA Extends Review for TransCon PTH in Hypoparathyroidism to August 2024
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesGreat britainJan mikkelsenAscendis pharmaRegulatory agencyDrug administrationAccess programDrug administration review of transconEuropean congressChief executiveExpanded access programComplete response letterMineral researchAscendis pharma announces extensionDrug administration review